SE0202719D0 - Process for mfg crystals of growth hormone - Google Patents
Process for mfg crystals of growth hormoneInfo
- Publication number
- SE0202719D0 SE0202719D0 SE0202719A SE0202719A SE0202719D0 SE 0202719 D0 SE0202719 D0 SE 0202719D0 SE 0202719 A SE0202719 A SE 0202719A SE 0202719 A SE0202719 A SE 0202719A SE 0202719 D0 SE0202719 D0 SE 0202719D0
- Authority
- SE
- Sweden
- Prior art keywords
- crystals
- functional derivatives
- growth hormone
- mfg
- propanol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormones [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Abstract
A process is provided for manufacturing crystals of growth hormone (GH), or functional derivatives thereof, comprising the following steps : (a) preparing an aqueous solution of GH, or functional derivatives thereof, comprising 2-propanol, (b) incubating the solution prepared in step (a) to crystallize said GH, or functional derivatives thereof, and (c) isolating the crystals formed in step (b). A novel use of 2-propanol as a crystallizing agent for manufacturing crystals of GH, or functional derivatives thereof is also provided. In addition, crystals obtainable by the process and pharmaceutical compositions comprising the crystals are provided. The crystals are useful as a medicament, for the manufacture of such a medicament, and in a method of treating a mammal, including man.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202719A SE0202719D0 (en) | 2002-09-13 | 2002-09-13 | Process for mfg crystals of growth hormone |
EP03795535A EP1539797A1 (en) | 2002-09-13 | 2003-09-12 | Process for manufacturing crystals of growth hormone |
BR0314187-0A BR0314187A (en) | 2002-09-13 | 2003-09-12 | Process for Producing Growth Hormone Crystals |
MXPA05002826A MXPA05002826A (en) | 2002-09-13 | 2003-09-12 | Process for manufacturing crystals of growth hormone. |
JP2004535333A JP2006513986A (en) | 2002-09-13 | 2003-09-12 | Method for producing growth hormone crystals |
AU2003259002A AU2003259002A1 (en) | 2002-09-13 | 2003-09-12 | Process for manufacturing crystals of growth hormone |
PCT/SE2003/001422 WO2004024753A1 (en) | 2002-09-13 | 2003-09-12 | Process for manufacturing crystals of growth hormone |
CA002498525A CA2498525A1 (en) | 2002-09-13 | 2003-09-12 | Process for manufacturing crystals of growth hormone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202719A SE0202719D0 (en) | 2002-09-13 | 2002-09-13 | Process for mfg crystals of growth hormone |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0202719D0 true SE0202719D0 (en) | 2002-09-13 |
Family
ID=20288983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0202719A SE0202719D0 (en) | 2002-09-13 | 2002-09-13 | Process for mfg crystals of growth hormone |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1539797A1 (en) |
JP (1) | JP2006513986A (en) |
AU (1) | AU2003259002A1 (en) |
BR (1) | BR0314187A (en) |
CA (1) | CA2498525A1 (en) |
MX (1) | MXPA05002826A (en) |
SE (1) | SE0202719D0 (en) |
WO (1) | WO2004024753A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2121186B1 (en) * | 2007-03-05 | 2019-10-30 | Rhodia Opérations | Method for following up the crystallisation of a substance |
GB201409451D0 (en) | 2014-05-28 | 2014-07-09 | Ipabc Ltd | Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5130298A (en) * | 1989-05-16 | 1992-07-14 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
US5109117A (en) * | 1990-06-26 | 1992-04-28 | Monsanto Company | Method of somatotropin naturation using urea and a soluble organic alcohol |
DK168790D0 (en) * | 1990-07-13 | 1990-07-13 | Novo Nordisk As | |
US5849704A (en) * | 1991-12-20 | 1998-12-15 | Novo Nordisk A/S | Pharmaceutical formulation |
SE9302278D0 (en) * | 1992-10-28 | 1993-07-02 | Kabi Pharmacia Ab | GROWTH HORMONE |
JP3723857B2 (en) * | 1998-02-04 | 2005-12-07 | 日本ケミカルリサーチ株式会社 | Aqueous pharmaceutical composition containing human growth hormone |
-
2002
- 2002-09-13 SE SE0202719A patent/SE0202719D0/en unknown
-
2003
- 2003-09-12 WO PCT/SE2003/001422 patent/WO2004024753A1/en active Search and Examination
- 2003-09-12 EP EP03795535A patent/EP1539797A1/en not_active Ceased
- 2003-09-12 JP JP2004535333A patent/JP2006513986A/en not_active Withdrawn
- 2003-09-12 AU AU2003259002A patent/AU2003259002A1/en not_active Abandoned
- 2003-09-12 BR BR0314187-0A patent/BR0314187A/en not_active IP Right Cessation
- 2003-09-12 MX MXPA05002826A patent/MXPA05002826A/en not_active Application Discontinuation
- 2003-09-12 CA CA002498525A patent/CA2498525A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2006513986A (en) | 2006-04-27 |
AU2003259002A1 (en) | 2004-04-30 |
BR0314187A (en) | 2005-08-09 |
MXPA05002826A (en) | 2005-09-30 |
WO2004024753A1 (en) | 2004-03-25 |
CA2498525A1 (en) | 2004-03-25 |
EP1539797A1 (en) | 2005-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003216879A1 (en) | Method for producing c13-alcohol mixtures | |
MXPA05008489A (en) | Manufacturing process for liposomal preparations. | |
WO2005065185A3 (en) | Temperature-stable formulations, and methods of development thereof | |
WO2004037789A3 (en) | Methylene urea derivatives as raf-kinase inhibitors | |
EA200600621A1 (en) | DERIVATIVES OF TETRAHYDRONAPTALINE, METHOD OF THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY MEANS | |
SG155046A1 (en) | Process for modifying drug crystal formation | |
ATE319702T1 (en) | METHOD FOR PRODUCING BENZOTHIOPHENE DERIVATIVES | |
HK1066545A1 (en) | Novel amlodipine camsylate and method for preparing thereof | |
ATE544445T1 (en) | PRODUCTION OF STERILE AQUEOUS SUSPENSIONS WITH MICRONIZED CRYSTALLINE ACTIVE INGREDIENTS FOR INHALATION | |
BRPI0413393A (en) | fexofenadine, pharmaceutically acceptable composition, antihistamine treatment method, composition, process for preparing fexofenadine and use of fexofenadine | |
DK1383540T3 (en) | Methods and pharmaceutical compositions for wound healing | |
EP1594885B8 (en) | Medicament for inhibiting tumour growth | |
HRP20050215A2 (en) | Intermediates in producing phenoxyacetic acid derivatives and method of using the same | |
WO2007052308A3 (en) | Glyco-phosphorylated biologically active agents | |
DE50301559D1 (en) | PROCESS FOR THE PREPARATION OF TOCOTRIENOL-ENRICHED PREPARATIONS | |
SE0202719D0 (en) | Process for mfg crystals of growth hormone | |
BR0317665A (en) | 1-alkyl-3-aminoindazoles | |
ATE428730T1 (en) | METHOD FOR PRODUCING AN ALPHA-1 ANTITRYPSINE SOLUTION | |
WO2002102978A3 (en) | Human growth hormone antagonists | |
WO2003053337A3 (en) | Therapeutic compositions | |
BRPI0306851A8 (en) | APPLICATION OF POLYSACCHARIDE DERIVATIVES AS ANTI-INFECTANT SUBSTANCES | |
SE9903611D0 (en) | Novel compounds III | |
PT1218401E (en) | 4-BENZYLAMINOQUINOLINS CONTAINED WITH BILIARY ACID AND ITS HETEROCYCLICS METHODS OF THEIR PRODUCTION MEDICINES CONTAINING THESE COMPOUNDS AND ITS APPLICATION | |
WO2004009608A3 (en) | Novel amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a, process for preparing the same, and use thereof | |
CA2449769A1 (en) | S-omeprazole (esomeprazole) inclusion complex with cyclodextrins |